MCL1 and lip and oral cavity carcinoma: These results demonstrate that PHA has strong antisurvival, proapoptotic, and antiangiogenic effects on HSC-3 human oral cancer cells, and these effects are mediated through control of the phosphorylation and expression of c-Met, Src, PKB, mTOR, Mcl-1, and HIF-1α.